OFFICIAL PUBLICATION OF

pdl.com.au

by its subsidiary APPco

Macular disease treatment PBS listed

Megan Haggan 11/05/2015

close up of green eye

Macular Disease Foundation Australia today applauded the Federal Government’s decision to place the registered drug ranibizumab (Lucentis) on the PBS, enabling patients affordable access to this sight saving treatment for Diabetic Macular Edema and Retinal Vein Occlusion. The Foundation has been advocating strongly for access and affordability for registered treatment for these serious macular diseases,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Eli Lilly clarifies Mounjaro availability

Lilly doesn't have needle production facilities. That is not their fault, you can't expect them to build a needle factory…

Tony Chiang

Funding secured for non-8CPA programs

Well done! Good to see pharmacy profession progressions

Wilson Tan

Funding secured for non-8CPA programs

Medschecks are part of the 8CPA. Have already had secured funding with indexation despite no evidence of value.

Big Pharma